Capital World Investors Legend Biotech Corp Transaction History

Capital World Investors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$57.25 - $69.74 $107,172 - $130,553	-1,872 Reduced 0.08%	2,385,960 $144 Million
Q3 2023 Nov 13, 2023	SELL	$63.16 - $76.5 $9,031 - $10,939	-143 Reduced 0.01%	2,387,832 $160 Million
Q2 2023 Aug 11, 2023	SELL	$46.28 - $75.01 $64,421 - $104,413	-1,392 Reduced 0.06%	2,387,975 $165 Million
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $12,157 - $16,063	-280 Reduced 0.01%	2,389,367 $115 Million
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $12,377 - $17,691	319 Added 0.01%	2,389,647 $119 Million
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $97,091 - $145,319	-2,545 Reduced 0.11%	2,389,328 $97.5 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $5.97 Million - $9.78 Million	177,849 Added 8.03%	2,391,873 $132 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $31.7 Million - $49.2 Million	1,020,545 Added 85.51%	2,214,024 $80.5 Million
Q4 2020 Feb 12, 2021	BUY	$25.8 - $32.39 $4.56 Million - $5.73 Million	176,860 Added 17.4%	1,193,479 $33.6 Million
Q3 2020 Nov 13, 2020	BUY	$27.5 - $39.61 $10.1 Million - $14.5 Million	366,619 Added 56.4%	1,016,619 $31.4 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $23.5 Million - $27.7 Million	650,000 New	650,000 $27.7 Million

212

77.9M

412K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.73B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.